MeiraGTx
MGTX
C$11.11
Share price
-1.94%
Change (1 day)
63.07%
Change (1 year)
Earnings for MeiraGTx (MGTX)
Earnings in 2025 (TTM): -C$0.22 Billion
According to MeiraGTx's latest financial reports the company's current earnings are C$34.5 Million. In 2024 the company made an earning of -C$0.19 Billion a decrease over its 2023 earnings that were of -C$97.46 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for MeiraGTx from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -C$0.22 Billion | 16.34% |
| 2024 | -C$0.19 Billion | 90.05% |
| 2023 | -C$97.46 Million | -43.22% |
| 2022 | -C$0.18 Billion | 57.27% |
| 2021 | -C$0.11 Billion | 37.02% |
| 2020 | -C$79.66 Million | 5.77% |
| 2019 | -C$75.32 Million | -34.34% |
| 2018 | -C$0.12 Billion | 168.72% |
| 2017 | -C$42.69 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -C$0.17 Billion | -24.05% | Jersey |
 Novavax NVAX | C$0.70 B | -430.73% | 🇺🇸 USA |
 Organovo ONVO | -C$3.43 Million | -98.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -C$0.11 Billion | -52.64% | 🇬🇧 UK |